Market Cap

Conversion Labs, Inc. Market Capitalization:

€47.75 Billion

EUR as of July 1, 2024

US$51.29 Billion

business Conversion Labs, Inc. Company Profile

Conversion Labs, Inc. Main Stock Listing

NASDAQ: CVLB

Market Capitalization History of Conversion Labs, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Pharmaceutical Retailers
Company Market Cap (USD)
Walgreens Boots Alliance, Inc. $9.58 B
Raia Drogasil SA $7.62 B
Alibaba Health Information Technology Ltd $6.63 B
Matsumotokiyoshi Holdings Co. Ltd $6.16 B
Corporativo Fragua, S.A.B. de C.V. $5.29 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Conversion Labs, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €61.43 B -20.41%
Jan. 1, 2023 €77.19 B 22.43%
Jan. 1, 2022 €63.05 B 0.74%
Jan. 1, 2021 €62.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Conversion Labs, Inc. Categories

United States languages Healthcare languages Pharmaceutical Retailers
United States Healthcare United States Pharmaceutical Retailers

Stocks & Indices

Conversion Labs, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CVLB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.